Characteristics of physical activities in daily life in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 171, Issue 9, 2005, Pages 972-977

  Pitta, Fabio ^b   Troosters, Thierry ^b   Spruit, Martijn A ^b   Probst, Vanessa S ^b   Decramer, Marc ^b   Gosselink, Rik ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

Chronic obstructive pulmonary disease; Controlled study; Correlates; DynaPort; Triaxial accelerometer

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; EXERCISE; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MONITOR; MUSCLE FORCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SITTING; STANDING; WALKING;

AGED; BODY MASS INDEX; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; WALKING;

EID: 18144389043     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200407-855OC     Document Type: Article

References (38)

1. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchaner D, Ettinger W, Heath GW, King AC, et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995;273:402-407.
2. Erikssen G. Physical fitness and changes in mortality: the survival of the fittest. Sports Med 2001;31:571-576.
3. Yohannes AM, Baldwin RC, Connolly M. Mortality predictors in disabling chronic obstructive pulmonary disease in old age. Age Ageing 2002;31:137-140.
4. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003;167:544-549.
5. Lee IM, Skerrett PJ. Physical activity and all-cause mortality: what is the dose-response relation? Med Sci Sports Exerc 2001;33:S459-S471.
6. American College of Sports Medicine position stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 1998;30:975-991.
7. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-586.
8. Restrick LJ, Paul EA, Braid GM, Cullinan P, Moore-Gillon J, Wedzicha JA. Assessment and follow up of patients prescribed long term oxygen treatment. Thorax 1993;48:708-713.
9. Schonhofer B, Ardes P, Geibel M, Kohler D, Jones PW. Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J 1997;10:2814-2819.
10. Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Validation of a triaxial accelerometer to assess various activities in COPD patients [abstract]. Am J Respir Crit Care Med 2004;169:A594.
11. Foglio K, Carone M, Pagani M, Bianchi L, Jones PW, Ambrosino N. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction. Respir Med 2000;94:256-263.
12. Pitta F, Troosters T, Spruit MA, Mortier S, Barbier V, Coosemans I, Van Vliet M, Decramer M, Gosselink R, et al. Physical activity level during daily life in COPD patients and age matched healthy controls: preliminary results [abstract]. Am J Respir Crit Care Med 2004;167:A772.
13. Pitta F, Troosters T, Spruit MA, Mortier S, Barbier V, Coosemans I, Van Vliet M, Decramer M, Gosselink R, et al. Physical activity level in daily life in COPD patients and healthy elderly subjects [abstract]. Eur Respir J 2004;24:631s.
14. Fabbri LM, Kurd SS. GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of COPD, 2003 update. Eur Res J. 2003;22:1-2.
15. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 2001;79:373-374.
16. Walsh LJ, Wong CA, Oborne J, Cooper S, Lewis SA, Pringle M, Coin A, Inelman EM, Enzi G. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 2001;56:279-284.
17. Peruzza S, Sergi G, Vianello A, Pisent C, Tiozzo F, Manzan A, Hubbard R, Tattersfield AE. Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life. Respir Med 2003;97:612-617.
18. Kjoller E, Kober L, Iversen K, Torp-Pedersen C. Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction. Eur J Heart Fail 2004;6:71-77.
19. Brandes M, Rosenbaum D. Correlations between the step activity monitor and the DynaPort ADL-monitor. Clin Biomechanics 2004;19:91-94.
20. Trost SG, Pate RR, Freedson PS, Sallis JF, Taylor WC. Using objective physical activity measures with youth: how many days of monitoring are needed? Med Sci Sports Exerc 2000;32:426-431.
21. Available from www.random.org (accessed December 2004).
22. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows: report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
23. Rochester DF, Arora NS. Respiratory muscle failure. Med Clin North Am 1983;67:573-597.
24. Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994;150:11-16.
25. Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985;66:69-74.
26. Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985;131:700-708.
27. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999;14:270-274.
28. Singh S, Morgan MD. Activity monitors can detect brisk walking in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2001;21:143-148.
29. Steele BG, Belza B, Cain K, Warms C, Coppersmith J, Howard J. Bodies in motion: monitoring daily activity and exercise with motion sensors in people with chronic pulmonary disease. J Rehabil Res Dev 2003;40:45-58.
30. Coronado M, Janssens JP, de Muralt B, Terrier P, Schutz Y, Fitting JW. Walking activity measured by accelerometry during respiratory rehabilitation. J Cardiopulm Rehabil 2003;23:357-364.
31. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003;58:100-105.
32. Belza B, Steele BG, Hunziker J, Lakshminaryan S, Holt L, Buchner DM. Correlates of physical activity in chronic obstructive pulmonary disease. Nurs Res 2001;50:195-202.
33. Steele BG, Holt L, Belza B, Ferris S, Lakshminaryan S, Buchner DM. Quantitating physical activity in COPD using a triaxial accelerometer. Chest 2000;117:1359-1367.
34. Troosters T, Gosselink R, Decramer M. Six-minute walk test: a valuable test, when properly standardized. Phys Ther 2002;82:826-827.
35. Sciurba F, Criner GJ, Lee SM, Mohsenifar Z, Shade D, Slivka W, Wise RA, and the National Emphysema Treatment Trial Research Group. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 2003;167:1522-1527.
36. Brooks D, Solway S, Gibbons WJ. ATS statement on six-minute walk test. Am J Respir Crit Care Med 2003;167:1287.
37. Soguel SN, Burdet L, de Muralt B, Fitting JW. Oxygen saturation during daily activities in chronic obstructive pulmonary disease. Eur Respir J 1996;9:2584-2589.
38. Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, Petersen NJ, Nahas Z, Goodnight-White S. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000;41:465-471.